PRISMA Checklist of The Efficacy and Safety of Pembrolizumab, Ipilimumab, and Nivolumab Monoteraphy and Combination for Colorectal Cancer: A Systematic Review and Meta-Analysis

Name: PRISMA Checklist of The Efficacy and Safety of Pembrolizumab, Ipilimumab, and Nivolumab Monoteraphy and Combination for Colorectal Cancer: A Systematic Review and Meta-Analysis
Creator: Albertus Ari Adrianto
Published: 2024-03-06T12:19:14.839Z
Keywords: Database

Adrianto, Albertus Ari; Riwanto, Ignatius; Sadhana, Udadi; Paramita, Dewi kartikawati; Setyawan, Henry; Tjandra, Kevin Christian; Respati, Danendra Rakha Putra; Rampengan, Derren; Ramadhan, Roy Novri; Jangkang, Gastin Gabriel; Mahati, Endang

doi:10.17632/zhvz39sggy.1

PRISMA Checklist of The Efficacy and Safety of Pembrolizumab, Ipilimumab, and Nivolumab Monoteraphy and Combination for Colorectal Cancer: A Systematic Review and Meta-Analysis

Published: 6 March 2024| Version 1 | DOI: 10.17632/zhvz39sggy.1

Contributors:

Albertus Ari Adrianto, Ignatius Riwanto, Udadi Sadhana, Dewi kartikawati Paramita, Henry Setyawan, Kevin Christian Tjandra, Danendra Rakha Putra Respati, Derren Rampengan, Roy Novri Ramadhan, Gastin Gabriel Jangkang, Endang Mahati

Description

This is the PRISMA Checklist of The Efficacy and Safety of Pembrolizumab, Ipilimumab, and Nivolumab Monoteraphy and Combination for Colorectal Cancer: A Systematic Review and Meta-analysis

Files

Institutions

Universitas Gadjah Mada Fakultas Kedokteran, Universitas Diponegoro Fakultas Kedokteran, Universitas Airlangga Fakultas Kedokteran, Universitas Sam Ratulangi Fakultas Kedokteran

PRISMA Checklist of The Efficacy and Safety of Pembrolizumab, Ipilimumab, and Nivolumab Monoteraphy and Combination for Colorectal Cancer: A Systematic Review and Meta-Analysis

Description

Files

Institutions

Categories

Licence